Neural tissue thermal ablation

"Neural tissue thermal ablation" is not a specific molecule, receptor, or canonical therapeutic target. Instead, it refers to a **procedure** that uses heat—delivered by methods such as radiofrequency energy or laser—to destroy targeted neural tissues. The goal is typically to disrupt the transmission of abnormal signals, such as those causing chronic pain or seizures. Common forms include **radiofrequency ablation** and **laser interstitial thermal therapy (LiTT)**. In these procedures, energy is delivered via probes under imaging guidance to heat and destroy specific nerves or brain regions responsible for disease symptoms. This approach is used in the treatment of chronic back and neck pain, epilepsy surgery for seizure foci, certain brain tumors, and other conditions where destruction of problematic neural tissue can provide clinical benefit[1][2][3]. Because "neural tissue thermal ablation" describes a technique rather than a molecular entity or druggable target class like "receptor," "enzyme," etc., it does not fit standard definitions for therapeutic targets in pharmacology or molecular medicine. Therefore: • It should not be considered a canonical therapeutic target. • There are no interacting drugs; instead, devices deliver energy. • No standard biomarkers exist specifically for this procedure. • Safety concerns relate to procedural risks rather than molecular off-target effects. If you are seeking information on the actual molecules affected by these procedures (e.g., ion channels on sensory neurons), please specify further so that more precise molecular targets can be identified.

Other names

Neural tissue ablationNerve ablationThermal ablation of neural tissueRadiofrequency nerve ablation (context-dependent)Laser interstitial thermal therapy (LiTT) (context-dependent)